Last reviewed · How we verify
NCT06189365
Amplatzer Amulet China Post Market Study (PMS)
trial testing Left Atrial Appendage (LAA) closure procedure with Amplatzer Amulet LAA occluder in Non-Valvular Atrial Fibrillation in 50 participants. Terminated before completion.
5 December 2025
Quick facts
| Lead sponsor | Abbott Medical Devices |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 30 January 2024 |
| Primary completion | 5 December 2025 |
| Estimated completion | 5 December 2025 |
| Sites | 5 locations across China |
Drugs / interventions tested
- Left Atrial Appendage (LAA) closure procedure with Amplatzer Amulet LAA occluder
Conditions studied
- Non-Valvular Atrial Fibrillation — all drugs for Non-Valvular Atrial Fibrillation →
Sponsor
Abbott Medical Devices — full company profile →
Who can join
18 and older, any sex, with Non-Valvular Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to prospectively evaluate the safety and effectiveness of the Amplatzer Amulet LAA occluder in a Chinese patient population indicated for use of this device.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06189365
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Non-Valvular Atrial Fibrillation
Currently open trials in the same condition.
- NCT04829929 — Evaluation of Safety and Performance of the Omega™ LAA (Left Atrial Appendage) Occluder and Omega™ Delivery System in Pa · NA · active not recruiting
Other Abbott Medical Devices trials
Trials by the same sponsor.
- NCT07421076 — Grid eXplore Mapping Study · NA · recruiting
- NCT07509658 — TriClip Japan Post-Approval Study · recruiting
- NCT07361445 — Agilis RF TSP Early Feasibility Study · NA · recruiting
- NCT07373353 — A Clinical Evaluation of AMJ-401 · NA · recruiting
- NCT07217392 — Left Bundle Branch Area Pacing (LBBAP) PMCF Study · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06189365 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Abbott Medical Devices
- Last refreshed: 18 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06189365.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing